The flu can also cause a general feeling of fatigue or malaise, Ray says, as well as gastrointestinal issues like diarrhea ...

Pfizer has released the full data from its phase 3 trial of an mRNA flu vaccine candidate, with the potential new shot demonstrating 34.5% greater efficacy compared to a control vaccine. | Pfizer has ...

Having the flu is a lousy experience, regardless of the type you have. While news of a rough flu season ahead (spurred by subclade K) continues to make headlines, there are two main types of flu, A ...

A quadrivalent nucleoside-modified messenger RNA influenza vaccine met superiority criteria compared with a licensed inactivated vaccine.

A new mRNA vaccine against the flu has proven itself more effective than existing vaccines in a new clinical trial. The ...

In a Phase 3 trial of more than 18,000 volunteers across three countries, an mRNA influenza vaccine from Pfizer has ...

LOS ANGELES (KABC) -- Sick patients are flooding doctor's offices as cases of the flu surge across Southern California. This year, a particularly potent B strain of the virus seems to be causing many ...

Pfizer-funded study finds a next-gen mRNA flu shot works better against current strains — but causes more short-term side ...

Pfizer's mRNA flu vaccine worked better than a standard flu shot in a large Phase 3 trial, researchers reported.

It has been said that the U.S. doesn’t have a healthcare system; but rather a disease management system We wait until diseases occur and then spend trillions of dollars trying to manage them, ...

As we get deeper into flu season, a new type of the influenza virus has been identified, the Centers for Disease Control and Prevention confirms.

The vaccine has been approved by HSA for use in individuals aged 2 to 49 years. Read more at straitstimes.com. Read more at straitstimes.com.